Vascepa is up for approval in China, with it's population of 1.4 million people, this year....opening up a huge market....Prices will need to be negotiated by Amarin's partner , Eddingpharm.
Amarin is unlikely to issue an AG until the European and Chinese markets come more into focus with decisions needing to be made about pricing and supply.
News 
Market Data 
Discover 
